Clinical Trials · NCT00835211
Desmopressin Acetate 0.2 mg Tablets, Fasting
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Teva Pharmaceuticals USA
- Enrollment
- 48
- Start date
- Jul 2003
- Locations
- 1 site, Canada
- Primary endpoint
- Cmax - Maximum Observed Concentration